Organ Transplantation for People Living with HIV/AIDS: Advances and Challenges
Sapna A. Mehta, MD, FIDSA
Director, Transplant Infectious Diseases
Clinical Director, NYU Langone Transplant Institute
Associate Professor of Medicine
NYU Grossman School of Medicine, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2021. All rights reserved.
Dr. Mehta is currently the Director of Transplant Infectious Diseases for the NYU Langone Transplant Institute and serves as the site investigator for the multicenter HOPE-in-Action clinical study- a study evaluating the feasibility and safety of HIV+ to HIV+ organ transplants. She is also the Clinical Director for the NYU Langone Transplant Institute, a role in which she helps lead the clinical operations and growth of the organ transplant programs. She is a fellow of the Infectious Diseases Society of America and currently co-chair of the HIV Working Group of the Infectious Diseases Community of Practice of the American Society of Transplantation.
At the completion of this educational session, learners will:
1. Understand the need for transplantation among people living with HIV in the United States.
2. Be aware of the current organ transplantation options for patients living with HIV
3. Learn about clinical study results to date evaluating outcomes of HIV-positive organ use for HIV-positive recipients
4. Recognize the need for greater awareness around HIV organ donation for PLWHA
This CME activity has approved for
AMA PRA Category 1 Credit™ for October 13, 2021 as a live activity. This activity will also be available as an enduring activity from October 14, 2021, through October 12, 2024.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to two (2) Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Sapna A. Mehta (Presenter) has no relevant financial relationships to disclose. Dr. Mehta will support her presentation and clinical recommendations with the best available evidence from the medical literature, and will submit her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
